바이오프로세스 기술 시장 : 부문별 예측(2025-2030년)

The Bioprocess Technology Market was valued at USD 21.16 billion in 2023, expected to reach USD 23.70 billion in 2024, and is projected to grow at a CAGR of 12.39%, to USD 47.95 billion by 2030.

Bioprocess technology encompasses the development and use of processes that utilize living cells or their components (such as enzymes) to obtain desired products. Its scope is increasingly wide, impacting sectors like pharmaceuticals, food and beverage, agriculture, and biofuels, essentially facilitating the production of biologically-derived products. The necessity of bioprocess technology lies in its ability to produce high-value products with sustainability, efficiency, and in some cases, greater specificity compared to chemical synthesis. Its applications range from the manufacturing of recombinant proteins and bio-based chemicals to vaccine development and wastewater treatment. The end-use scope extends to industries such as healthcare, where it aids in the production of innovative therapeutics, and agriculture, where it supports biofertilizers and biopesticides. The market is currently influenced by the growing demand for personalized medicine and sustainable agricultural practices, alongside advancements in biomanufacturing techniques and increased investment in biotechnology research. However, challenges such as stringent regulatory frameworks, high initial capital, and technical complexities can impede market growth. Opportunities arise from increasing governmental and private sector funding directed towards biotechnology startups, alongside the rising trend of mergers and acquisitions to boost research capabilities. Companies can capitalize on these opportunities by innovating in areas like cell line development, bioprocess optimization through artificial intelligence, and integrated continuous bioprocessing. The nature of the market is highly dynamic and competitive, driven by rapid technological advancements and a growing emphasis on eco-friendly production processes. Best areas for innovation include developing robust and scalable bioprocess systems, enhancing upstream and downstream process efficiencies, and leveraging digital tools for process monitoring and control. Successful navigation of this market requires firms to keep abreast of technological trends while addressing regulatory and operational challenges to sustain growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprocess Technology Market

The Bioprocess Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infectious and chronic diseases
  • Shifting preference towards bio-based products derived from biodegradable and fossil fuels
  • Rise in outsourcing of manufacturing activities to CMOs, CROs, and CDMOs
• Market Restraints
  • High cost of technology
• Market Opportunities
  • Increase in funding for R&D of bioprocess technology
  • Technological advancements in the bioprocess technology
• Market Challenges
  • Stringent regulatory policies

Porter's Five Forces: A Strategic Tool for Navigating the Bioprocess Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprocess Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprocess Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprocess Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprocess Technology Market

A detailed market share analysis in the Bioprocess Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprocess Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprocess Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprocess Technology Market

A strategic analysis of the Bioprocess Technology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Technology Market, highlighting leading vendors and their innovative profiles. These include Advanced Instruments LLC, Asahi Kasei Medical Co., Ltd., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Catalent Biologics, Colder Products Company by Dover Electronics, Corning Inc., Danaher Corp., Emerson Electric Co., Eppendorf SE, F. Hoffmann-La Roche AG, Getinge AB, Koninklijke Philips N.V., Lonza Group AG, Merck KGaA, Repligen, Sartorious AG, Solida Biotech GmBH, STADA Arzneimittel AG, and Univercells Group.

Market Segmentation & Coverage

This research report categorizes the Bioprocess Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables & Accessories and Instruments. The Consumables & Accessories is further studied across Culture Media and Reagents. The Instruments is further studied across Bioprocess Analyzers, Bioreactors, Blood Gas Analyzers, Cell Counter, Incubators, and Osmometers.
• Based on Application, market is studied across Antibiotics, Biosimilar, Monoclonal Antibodies, Primary Surgical, and Recombinant Proteins.
• Based on End-User, market is studied across Academic Research Organization, Biopharmaceutical Companies, Contract Manufacturing Organization, Contract Research Organization, and Food & Feed Industry.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infectious and chronic diseases
    • 5.1.1.2. Shifting preference towards bio-based products derived from biodegradable and fossil fuels
    • 5.1.1.3. Rise in outsourcing of manufacturing activities to CMOs, CROs, and CDMOs
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of technology
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in funding for R&D of bioprocess technology
    • 5.1.3.2. Technological advancements in the bioprocess technology
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory policies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioprocess Technology Market, by Product

• 6.1. Introduction
• 6.2. Consumables & Accessories
  • 6.2.1. Culture Media
  • 6.2.2. Reagents
• 6.3. Instruments
  • 6.3.1. Bioprocess Analyzers
  • 6.3.2. Bioreactors
  • 6.3.3. Blood Gas Analyzers
  • 6.3.4. Cell Counter
  • 6.3.5. Incubators
  • 6.3.6. Osmometers

7. Bioprocess Technology Market, by Application

• 7.1. Introduction
• 7.2. Antibiotics
• 7.3. Biosimilar
• 7.4. Monoclonal Antibodies
• 7.5. Primary Surgical
• 7.6. Recombinant Proteins

8. Bioprocess Technology Market, by End-User

• 8.1. Introduction
• 8.2. Academic Research Organization
• 8.3. Biopharmaceutical Companies
• 8.4. Contract Manufacturing Organization
• 8.5. Contract Research Organization
• 8.6. Food & Feed Industry

9. Americas Bioprocess Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bioprocess Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Instruments LLC
• 2. Asahi Kasei Medical Co., Ltd.
• 3. Becton Dickinson and Company
• 4. Boehringer Ingelheim International GmbH
• 5. Catalent Biologics
• 6. Colder Products Company by Dover Electronics
• 7. Corning Inc.
• 8. Danaher Corp.
• 9. Emerson Electric Co.
• 10. Eppendorf SE
• 11. F. Hoffmann-La Roche AG
• 12. Getinge AB
• 13. Koninklijke Philips N.V.
• 14. Lonza Group AG
• 15. Merck KGaA
• 16. Repligen
• 17. Sartorious AG
• 18. Solida Biotech GmBH
• 19. STADA Arzneimittel AG
• 20. Univercells Group